Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-604
Closed -$46K 1458
2026
Q1
$46K Hold
604
0.01% 515
2025
Q4
$45K Hold
604
0.01% 500
2025
Q3
$41K Hold
604
﹤0.01% 521
2025
Q2
$39K Hold
604
﹤0.01% 516
2025
Q1
$37K Sell
604
-74
-11% -$4.9K ﹤0.01% 512
2024
Q4
$49K Sell
678
-7
-1% -$547 0.01% 455
2024
Q3
$56K Buy
685
+20
+3% +$1.6K 0.01% 435
2024
Q2
$49K Sell
665
-11
-2% -$825 0.01% 446
2024
Q1
$53K Buy
676
+22
+3% +$1.64K 0.01% 430
2023
Q4
$47K Buy
654
+32
+5% +$2.23K 0.01% 432
2023
Q3
$43K Hold
622
0.01% 440
2023
Q2
$50K Buy
622
+415
+200% +$33.9K 0.01% 424
2023
Q1
$17K Sell
207
-415
-67% -$33.4K ﹤0.01% 478
2022
Q4
$16K Buy
622
+415
+200% +$29.6K ﹤0.01% 487
2022
Q3
$13K Buy
207
+5
+2% +$346 ﹤0.01% 503
2022
Q2
$14K Buy
202
+13
+7% +$965 ﹤0.01% 467
2022
Q1
$15K Sell
189
-5
-3% -$360 ﹤0.01% 471
2021
Q4
$15K Buy
+194
New +$14.3K ﹤0.01% 464

Other funds holding HOLX

Capital Advisors Ltd's HOLX Position: Q2 2026 in Review

Capital Advisors Ltd sold out of Hologic (HOLX) in Q2 2026, closing a stake of 604 shares — an estimated $46K sold.

Capital Advisors Ltd first reported a position in HOLX in Q4 2021 and held it in 18 quarters. The position peaked at $56K in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Capital Advisors Ltd reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Capital Advisors Ltd sold 604 Hologic shares in Q2 2026, an estimated $46K.
  • Capital Advisors Ltd first reported a position in Hologic in Q4 2021 and held it in 18 quarters.
  • Capital Advisors Ltd's Hologic position peaked at $56K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.